Ihr Suchergebnis
Sie recherchieren derzeit unangemeldet.Melden Sie sich an (Login) um den vollen Funktionsumfang der Datenbank nutzen zu können.
In der Rubrik News haben wir 23543 Angebote für Sie gefunden
-
Heritage Global Inc. Provides Auction Results From July Pharmaceutical Sector Sale
27.07.2020Heritage Global Inc., an asset services company specializing in financial and capital assets, today announced results from its ongoing monthly Pharmaceutical Sector Sale for July. With over 600 items for sale, the 100% online auction received 45,000 page views, more than 9,500 internet bids and generated in excess of one million dollars in asset sales. Furthermore, over 250 companies registered to
-
Apic Bio Announces Formation of Scientific Advisory Board
27.07.2020Apic Bio, Inc. today announced the formation of its Scientific Advisory Board (SAB) which includes internationally recognized gene therapy experts. The SAB will provide clinical and scientific expertise to help the Company advance its pipeline and leverage its proprietary silence and replace THRIVE™ platform. Apic’s CEO, John Reilly, MS/MBA, stated, "As we continue to advance our programs, it is critical that we obtain input from individuals with diverse
-
Walgreens Boots Alliance Announces Transition of Leadership to Continue Significant Progress on Key Strategic Priorities and Drive Future Success
27.07.2020Stefano Pessina Has Informed the Board of His Decision to Step Down as CEO, to Become Executive Chairman of the Board Once New CEO Is Named / James Skinner Will Step down as Executive Chairman at That Time, and Remain on the Board
-
Research Opens New Neural Network Model Pathway to Understanding the Brain
27.07.2020NTT Research Embraces PHI Lab Scientist-led Paper and Academic Initiatives that Set Firmer Foundation for Neuroscientific Models
-
4D Molecular Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial of 4D-110 by Intravitreal Injection for the Treatment of Choroideremia
27.07.20204D Molecular Therapeutics (4DMT), a clinical-stage leader in the development of precision-guided AAV gene medicines based on directed evolution, announced that the first patient has been dosed in the Phase 1 clinical trial of 4D-110, a Roche-licensed product candidate, delivered by a single intravitreal injection for Choroideremia. Choroideremia is a blinding and currently untreatable X-linked inherited retinal disease.
-
Kleinere Maße, höhere Leistung
27.07.2020Mit den Sicherheitskupplungen der Typen SKX-L und SKB bietet die JAKOB Antriebstechnik GmbH eine Sicherheitskupplungsgeneration zur Überlastbegrenzung bzw. zum Kollisionsschutz für indirekte Antriebe vor, die den modernsten Anforderungen gerecht wird.
-
USA verdoppeln Investitionen in Modernas Covid-19-Impfstoffkandidaten
28.07.2020Die US-Regierung wird Zusatzkosten einer deutlich ausgeweiteten Phase-3-Studie für den Corona-Impfstoffkandidaten des Biotechnolgie-Unternehmens Moderna übernehmen. Wegen einer signifikant höheren Anzahl an Probanden benötige das Unternehmen zusätzliche Investitionen im Umfang von bis
-
Zurück zur Schule - Wie umgehen mit dem Corona-Risiko im Klassenraum?
28.07.2020Man hat sich lange nicht gesehen, den Kopf durchgelüftet, sich verändert: Die Rückkehr zur Schule nach den Sommerferien war schon immer etwas aufregend. In Zeiten von Corona gilt das nicht mehr nur für Schüler, Eltern und Lehrkräfte. Auch Politiker, Ärzte, Virologen und andere Fachleute
-
Forte Biosciences, Inc. Reports Inducement Grants Under NASDAQ Listing Rules
28.07.2020Forte Biosciences, Inc. (www.fortebiorx.com), a clinical-stage biopharmaceutical company, today announced the issuance of equity inducement awards as required by the Nasdaq Stock Market Rules. In accordance with NASDAQ Listing Rule 5635(c)(4), the Compensation Committee of Forte’s Board of Directors approved the grants of equity awards to purchase a total of 155,000 shares of common stock to three new non-executive employees as a material
-
Analysis on Impact of COVID-19- Global Clinical Mass Spectrometry Market 2020-2024 | Evolving Opportunities with Agilent Technologies Inc. and Bruker Corp.
28.07.2020The global clinical mass spectrometry market size is expected to grow by USD 1.70 billion as per Technavio. This marks a significant market growth compared to the 2019 growth estimates due to the impact of the COVID-19 pandemic in the first half of 2020. Moreover, steady growth is expected to continue throughout the forecast period, and the market is expected to grow at a CAGR of 6%.
Sie sehen Artikel 9101 bis 9110 von insgesamt 23543
- Erste Seite
- 909
- 910
- 911
- 912
- 913
- Letzte Seite
